Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070484 · ClinicalTrials.gov registry record · NA
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02070484: Clinical Trial NA study, sponsored by OhioHealth.
NCT02070484 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02070484, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
Primary Outcome
The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.
Interventions
- BIOLOGICAL NuCel
- BIOLOGICAL Demineralized Bone Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-03-24 |
| Phase | NA |
Why NCT02070484 stopped before completion
NCT02070484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which NuCel is the first listed.
NCT02070484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02070484 about?
NCT02070484 is a clinical study titled "Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease". The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
What is the current status of trial NCT02070484?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-02. Estimated completion is 2017-03-24.
What interventions are being tested in trial NCT02070484?
The interventions under investigation include: NuCel (BIOLOGICAL), Demineralized Bone Matrix (BIOLOGICAL).
Who is sponsoring clinical trial NCT02070484?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02070484's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia